Best of luck, buspirone has been studied much more in women.alexc wrote: ↑Sun Jul 19, 2020 11:52 pm Well, I decided to bite the bullet and give Buspirone a try since I responded so well to it more than 12 years ago while I took it a along with Prozac. Back then I was on very high doses of Prozac and 60mg Buspirone. Since they are almost opposing forces in some sense – – when it comes to libido and function – – I am hoping I can keep the dose much lower since I will be taking it alone. Today was day three at 5 mg three times per day. I have not had any side effects other than a mild headache. I used to have extremely severe OCD and fortunately have recovered 95% over the course of the last 12 years without any medications; using only cognitive diversion and supplements. I will post back my experience with the Buspirone.
Try to have intercourse like after 1-1.5 h after a pill.
There is also a company optimizing the dosage alongside small dose testosterone for the best result, and also put a new patented drug on the market.
As far as I know, buspirone has a very rapid elimination, so optimizing the usage is a must.
The last publication was just about checking pharmacokinetics and food influence on plasma concentration.
Then they plan to have a protocol optimized to be used on demand, lots of data analysis, precision and personalized medicine.
Gerritsen J, Bloemers J, Van Rooij K, De Leede L, Van der Geest R, Frijlink H, Koppeschaar H, Olivier B, Tuiten A. The effect of food on the pharmacokinetics of buspirone after single administration of a sublingual testosterone and oral buspirone combination tablet in healthy female subjects. Accepted for publication in Sex Med
https://emotionalbrain.nl/?page_id=27
https://clinicaltrials.gov/ct2/show/NCT02101203
The study was done on middle-aged women, N=497
http://www.pharmajournalist.com/emotion ... -lybridos/
" Lybridos is specifically designed for women with FSIAD as a result of an overactive sexual inhibition system in the brain. Results reveal incredible changes in satisfactory sexual events from baseline as compared to placebo and monotherapy thus outdoing placebo and monotherapy eventually."